RALLYBIO CORP (RLYB) Fundamental Analysis & Valuation

NASDAQ:RLYB • US75120L2097

Current stock price

8.29 USD
0 (0%)
Last:

This RLYB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RLYB Profitability Analysis

1.1 Basic Checks

  • RLYB had negative earnings in the past year.
  • RLYB had a negative operating cash flow in the past year.
  • RLYB had negative earnings in each of the past 5 years.
  • RLYB had a negative operating cash flow in each of the past 5 years.
RLYB Yearly Net Income VS EBIT VS OCF VS FCFRLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • RLYB's Return On Assets of -14.42% is fine compared to the rest of the industry. RLYB outperforms 78.68% of its industry peers.
  • RLYB has a Return On Equity of -15.49%. This is amongst the best in the industry. RLYB outperforms 84.11% of its industry peers.
Industry RankSector Rank
ROA -14.42%
ROE -15.49%
ROIC N/A
ROA(3y)-54.58%
ROA(5y)-45.3%
ROE(3y)-59.81%
ROE(5y)-49.11%
ROIC(3y)N/A
ROIC(5y)N/A
RLYB Yearly ROA, ROE, ROICRLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • RLYB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RLYB Yearly Profit, Operating, Gross MarginsRLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. RLYB Health Analysis

2.1 Basic Checks

  • RLYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RLYB has more shares outstanding
  • Compared to 5 years ago, RLYB has more shares outstanding
  • There is no outstanding debt for RLYB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RLYB Yearly Shares OutstandingRLYB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M
RLYB Yearly Total Debt VS Total AssetsRLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -1.32, we must say that RLYB is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.32, RLYB is in line with its industry, outperforming 51.55% of the companies in the same industry.
  • There is no outstanding debt for RLYB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.32
ROIC/WACCN/A
WACC9.52%
RLYB Yearly LT Debt VS Equity VS FCFRLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • RLYB has a Current Ratio of 14.50. This indicates that RLYB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 14.50, RLYB belongs to the top of the industry, outperforming 90.31% of the companies in the same industry.
  • A Quick Ratio of 14.50 indicates that RLYB has no problem at all paying its short term obligations.
  • RLYB has a better Quick ratio (14.50) than 90.31% of its industry peers.
Industry RankSector Rank
Current Ratio 14.5
Quick Ratio 14.5
RLYB Yearly Current Assets VS Current LiabilitesRLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. RLYB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.24% over the past year.
  • RLYB shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.91%.
EPS 1Y (TTM)48.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.5%
Revenue 1Y (TTM)34.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%484.21%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.22% on average over the next years. This is quite good.
  • Based on estimates for the next years, RLYB will show a very strong growth in Revenue. The Revenue will grow by 273.52% on average per year.
EPS Next Y11.88%
EPS Next 2Y15.89%
EPS Next 3Y12.68%
EPS Next 5Y15.22%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y273.52%

3.3 Evolution

RLYB Yearly Revenue VS EstimatesRLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2029 2030 2031 200M 400M 600M 800M
RLYB Yearly EPS VS EstimatesRLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. RLYB Valuation Analysis

4.1 Price/Earnings Ratio

  • RLYB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RLYB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RLYB Price Earnings VS Forward Price EarningsRLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RLYB Per share dataRLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • RLYB's earnings are expected to grow with 12.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.89%
EPS Next 3Y12.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RLYB Dividend Analysis

5.1 Amount

  • RLYB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RLYB Fundamentals: All Metrics, Ratios and Statistics

RALLYBIO CORP

NASDAQ:RLYB (4/21/2026, 8:10:43 PM)

8.29

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-16
Earnings (Next)05-12
Inst Owners56.5%
Inst Owner Change8.65%
Ins Owners2.41%
Ins Owner Change0%
Market Cap43.85M
Revenue(TTM)858.00K
Net Income(TTM)-8.98M
Analysts45.71
Price Target8.16 (-1.57%)
Short Float %23.64%
Short Ratio5.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.95%
Min EPS beat(2)13.94%
Max EPS beat(2)35.96%
EPS beat(4)4
Avg EPS beat(4)20.67%
Min EPS beat(4)11.96%
Max EPS beat(4)35.96%
EPS beat(8)8
Avg EPS beat(8)16.33%
EPS beat(12)11
Avg EPS beat(12)12.81%
EPS beat(16)13
Avg EPS beat(16)10.73%
Revenue beat(2)2
Avg Revenue beat(2)137.49%
Min Revenue beat(2)63.24%
Max Revenue beat(2)211.75%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)700%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-700%
EPS NY rev (1m)0%
EPS NY rev (3m)-700%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 51.11
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)-5.59
EYN/A
EPS(NY)-4.93
Fwd EYN/A
FCF(TTM)-5.64
FCFYN/A
OCF(TTM)-5.64
OCFYN/A
SpS0.16
BVpS10.96
TBVpS10.96
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -14.42%
ROE -15.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.58%
ROA(5y)-45.3%
ROE(3y)-59.81%
ROE(5y)-49.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.5
Quick Ratio 14.5
Altman-Z -1.32
F-Score5
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.5%
EPS Next Y11.88%
EPS Next 2Y15.89%
EPS Next 3Y12.68%
EPS Next 5Y15.22%
Revenue 1Y (TTM)34.91%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%484.21%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y273.52%
EBIT growth 1Y46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.51%
OCF growth 3YN/A
OCF growth 5YN/A

RALLYBIO CORP / RLYB Fundamental Analysis FAQ

What is the fundamental rating for RLYB stock?

ChartMill assigns a fundamental rating of 3 / 10 to RLYB.


What is the valuation status for RLYB stock?

ChartMill assigns a valuation rating of 0 / 10 to RALLYBIO CORP (RLYB). This can be considered as Overvalued.


How profitable is RALLYBIO CORP (RLYB) stock?

RALLYBIO CORP (RLYB) has a profitability rating of 1 / 10.


How financially healthy is RALLYBIO CORP?

The financial health rating of RALLYBIO CORP (RLYB) is 7 / 10.